Rethinking the pharma R&D lifecycle with AI in mind
Drug Discovery World
AUGUST 7, 2024
Failing to reimagine R&D systems to handle the new speed and scale of AI-driven discovery risks over-promising and under-delivering to the people who need new medicines. The power of AI is being throttled by our R&D system There’s no question that new AI models for drug discovery deserve serious attention.
69 
Let's personalize your content